4//SEC Filing
Bjork Elisabeth 4
Accession 0001140361-22-023149
CIK 0001281895other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 9:07 PM ET
Size
16.1 KB
Accession
0001140361-22-023149
Insider Transaction Report
Form 4
Bjork Elisabeth
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-13+47,745→ 47,745 totalExercise: $10.77Exp: 2032-06-13→ Common Stock (47,745 underlying) - Award
Stock Option (Right to Buy)
2022-06-13$6.80/sh+7,345$49,946→ 7,345 totalExercise: $10.77Exp: 2032-06-13→ Common Stock (7,345 underlying)
Footnotes (2)
- [F1]This option represents a right to purchase a total of 47,745 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023.
- [F2]This option represents a right to purchase a total of 7,345 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023. This option was issued to the Reporting Person in lieu of director retainer fees of $50,000.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001810406
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 9:07 PM ET
- Size
- 16.1 KB